Add
PPHM to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| PPHM > SEC Filings for PPHM > Form 8-K on 16-Jul-2012 | All Recent SEC Filings |
16-Jul-2012
Results of Operations and Financial Condition, Regulation FD Disclo
On July 16, 2012, Peregrine Pharmaceuticals, Inc. issued a press release to report the Company's financial results for the fourth quarter and fiscal year ended April 30, 2012. A copy of the press release is attached to this current report on Form 8-K as Exhibit 99.1. No additional information is included in this Current Report on Form 8-K.
The information included in this Current Report on Form 8-K, including the exhibit hereto, shall not be deemed "filed" for purposes of, nor shall it be deemed incorporated by reference in, any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as expressly set forth by specific reference in such a filing.
On July 16, 2012, at 4:30 p.m. EDT/1:30 p.m. PDT, the Company hosted a conference call to discuss its fourth quarter and fiscal year ended April 30, 2012 financial results. The webcast of the conference call will be archived on the Company's website for approximately 30 days.
(d) Exhibits. The following material is filed as an exhibit to this Current Report on Form 8-K:
Exhibit
Number
99.1 Press Release issued July 16, 2012
|
|